about
Hostility in schizophrenia: An integrated analysis of the combined Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) and the European First Episode Schizophrenia Trial (EUFEST) studiesEffectiveness of antipsychotic drugs against hostility in patients with schizophrenia in the Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) study.A meta-analysis of the Val158Met COMT polymorphism and violent behavior in schizophrenia.Effectiveness of antipsychotic treatments in a nationwide cohort of patients in community care after first hospitalisation due to schizophrenia and schizoaffective disorder: observational follow-up study.Differential regulation of catechol-O-methyltransferase expression in a mouse model of aggression.Violent behavior in mental illness: the role of substance abuse.Measurement of agitation and aggression in adult and aged neuropsychiatric patients: review of definitions and frequently used measurement scales.Clozapine, olanzapine, risperidone, and haloperidol in the treatment of patients with chronic schizophrenia and schizoaffective disorder.Antipsychotic-induced weight gain and therapeutic response: a differential association.Neurocognitive effects of clozapine, olanzapine, risperidone, and haloperidol in patients with chronic schizophrenia or schizoaffective disorder.Neurocognitive correlates of the COMT Val(158)Met polymorphism in chronic schizophrenia.COMT158 polymorphism and hostility.Efficacy of clozapine, olanzapine, risperidone, and haloperidol in schizophrenia and schizoaffective disorder assessed with nurses observation scale for inpatient evaluation.History of violent behaviour and schizophrenia in different cultures. Analyses based on the WHO study on Determinants of Outcome of Severe Mental Disorders.Very long-term outcome of schizophrenia.Electroencephalograms of XYY and XXY men.Catechol-O-methyltransferase and Monoamine Oxidase-A Polymorphisms and Treatment Response to Typical and Atypical NeurolepticsEffect of nitrazepam, amylobarbitone sodium and placebo on the electroencephalogram of normal subjectsEEG CHANGES IN STATES FOLLOWING PROFESSIONAL CARBON DISULPHIDE POISONINGTriggering Violence in Psychosis
P50
Q24289439-D6C704C3-8F7A-4AE6-8C07-24E6C7079F71Q33826250-9903D7B0-7C9D-449B-8170-01599FC83BEFQ34385060-1F3A25CB-1C17-44AE-A771-BB1CAC1AB95BQ34873532-A407CA06-8FFC-4F8D-B8D6-198F0E84747EQ35421990-D0B50005-AEE0-4703-9B41-6ECDBCDBB441Q36807170-F45DAEA6-B38B-4A7F-870A-5DB6A6927CBDQ39126844-E02E2C5C-BCE8-43A6-A3FC-333595B11FDEQ43873918-33ACA81E-C7FE-44B6-A773-A111589BA198Q43990349-39CE4EC3-219A-404E-AD41-A653CD4D764CQ44013096-38BABFF9-3B09-41CF-8748-91E7D215A65AQ44174109-3A7C9BE8-1157-4D0D-A3DD-80EA3F3F18AEQ44860126-39D5540F-979E-45F1-87D4-EFAF273B472BQ46520547-66CC63C6-33E0-48C5-82FE-D501E4E8E4C7Q47785963-7521865A-51E3-4F1D-8865-6BB9031CE74AQ52565151-FF7D2242-B939-4117-814E-436041496AF0Q52859212-4D2B5A8F-A9BE-467A-8FB3-6E670BD65964Q56791166-9843941F-306A-4828-AC92-E176AFA15800Q69891094-6B2B41BF-49D9-40D9-A3E3-276E2B226FDCQ76877843-AB585216-2048-47F8-85EF-A6212563D4F1Q87885753-1A830043-6A0C-468F-9D57-FCD98AAAFC9E
P50
description
psychiatr
@cs
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Jan Volavka
@ast
Jan Volavka
@cs
Jan Volavka
@en
Jan Volavka
@es
Jan Volavka
@nl
type
label
Jan Volavka
@ast
Jan Volavka
@cs
Jan Volavka
@en
Jan Volavka
@es
Jan Volavka
@nl
prefLabel
Jan Volavka
@ast
Jan Volavka
@cs
Jan Volavka
@en
Jan Volavka
@es
Jan Volavka
@nl
P1006
P214
P1006
P214
P31
P496
0000-0002-4178-8207
P569
1934-12-29T00:00:00Z
P691
nlk20030145289
P7859
lccn-n94803274